Sulfaquinoxaline Sodium Global Buyers List: Comprehensive Market Guide for Importers and Distributors

Sulfaquinoxaline Sodium (CAS 967-80-6), also known as SQ-Na, is a vital veterinary sulfonamide antibiotic widely used in livestock and poultry production. As global demand for animal protein continues to rise, the market for this essential antimicrobial agent has experienced steady growth, with the global market valued at approximately USD 45 million in 2024 and projected to reach USD 68 million by 2033.

For manufacturers, exporters, and distributors seeking to expand their reach in this growing market, understanding the global buyer landscape is crucial. This comprehensive guide provides insights into the Sulfaquinoxaline Sodium global buyers list, market dynamics, key purchasing regions, and strategies for connecting with qualified importers.

Understanding Sulfaquinoxaline Sodium

Product Overview

Sulfaquinoxaline Sodium is a sodium salt form of sulfaquinoxaline, belonging to the sulfonamide class of antibiotics. Its molecular formula is C₁₄H₁₁N₄NaO₂S with a molecular weight of 322.32. The compound appears as a yellow powder and is highly soluble in water.

Primary Applications

This veterinary API serves several critical functions in animal health:

  • Coccidiosis Treatment and Prevention: Sulfaquinoxaline Sodium is primarily used to treat and prevent coccidiosis in poultry, cattle, sheep, and other livestock. The compound targets protozoan parasites of the Eimeria species.
  • Broad-Spectrum Antimicrobial Activity: It exhibits activity against both Gram-negative and Gram-positive bacteria, making it valuable for treating various bacterial infections.
  • Mechanism of Action: The drug works by inhibiting bacterial folate synthesis. As a structural analog of para-aminobenzoic acid (PABA), it competitively inhibits dihydropteroate synthase, an enzyme essential for folic acid production in pathogens.

Quality Specifications

Commercial Sulfaquinoxaline Sodium typically offers purity ranging from 97.67% to 99.72%. Products are available in various formulations including powder and salt forms, with storage recommended at 0-6°C.

Global Market Overview

Market Size and Growth Projections

The Sulfaquinoxaline Sodium market has demonstrated consistent growth trajectory. Market research indicates:

  • 2024 Market Value: USD 45 million
  • 2033 Projection: USD 68 million
  • Compound Annual Growth Rate (CAGR): 4.2% (2026–2033)

This growth is driven by increasing global meat consumption, rising awareness of animal health management, and the expansion of intensive livestock farming operations worldwide.

Regional Market Distribution

The global Sulfaquinoxaline Sodium market spans multiple regions, each with distinct buyer characteristics:

Asia-Pacific: Dominates both production and consumption, with China serving as the largest manufacturing hub and a significant consumer market. Key markets include China, India, Indonesia, Malaysia, Japan, and South Korea.

Europe: A substantial importer of Sulfaquinoxaline Sodium, with major buyers in Germany, the United Kingdom, France, Italy, Spain, and the Netherlands. European buyers typically demand high-quality standards and regulatory compliance.

North America: The United States, Canada, and Mexico represent significant markets, with buyers often requiring GMP-certified products and Drug Master Files (DMF).

South America: Brazil and Argentina are emerging as important markets for veterinary pharmaceuticals.

Middle East and Africa: Countries including Saudi Arabia, UAE, Kuwait, and Qatar show growing demand.

Sulfaquinoxaline Sodium Global Buyers: Who Are They?

Understanding the buyer landscape requires categorizing the various types of purchasers in the supply chain:

1. Veterinary Pharmaceutical Manufacturers

These are the primary buyers of Sulfaquinoxaline Sodium API. They incorporate the active ingredient into finished veterinary drug products, including:

  • Oral powders and solutions
  • Feed additives
  • Injectable formulations
  • Combination products (e.g., with Amprolium and Vitamin K)

2. Animal Health Product Distributors

Distributors and wholesalers purchase Sulfaquinoxaline Sodium in bulk quantities for resale to veterinary clinics, farms, and pharmaceutical manufacturers in their respective regions.

3. Large-Scale Livestock Operations

Integrated poultry and cattle operations sometimes purchase Sulfaquinoxaline Sodium directly for on-site formulation or incorporation into animal feed.

4. Trading Companies and Importers

International trading companies facilitate cross-border transactions, particularly between manufacturing hubs like China and consuming regions worldwide. These entities often maintain extensive Sulfaquinoxaline Sodium global buyers lists and handle logistics, customs clearance, and regulatory compliance.

5. Government and Institutional Buyers

Agricultural ministries, veterinary services, and government procurement agencies in various countries purchase Sulfaquinoxaline Sodium for public health programs and disease control initiatives.

Key Sulfaquinoxaline Sodium Manufacturers and Suppliers

For buyers seeking reliable sources, several established manufacturers dominate the global supply landscape:

Major API Manufacturers

Nanhai Beisha Pharmaceutical Co., Ltd.

  • Location: Foshan, Guangdong, China
  • One of the largest API manufacturers in South China
  • Annual output exceeding 3,000 metric tons, accounting for approximately 40% of global sulfonamide production
  • Products exported to Europe, US, Japan, and Southeast Asia
  • Holds GMP certification for veterinary drugs and has passed US FDA on-site inspection
  • Accredited by EDQM, Japanese Ministry of Health, Labour and Welfare, and other regulatory bodies

Yichang Sanxia Pharmaceutical Co., Ltd.

  • Listed on PharmaCompass with USDMF, CEP/COS, JDMF, and other certifications

Anhui Sinotech Industrial

  • Provides API manufacturing services with multiple regulatory certifications

Shanghai Zhongxi Sunve Pharmaceutical Co., Ltd.

  • Holds USDMF, CEP/COS, and other international quality certifications

Wugan Pharmaceutical (Suzhou) Co., Ltd.

  • Documented as a supplier of Sulfaquinoxaline Sodium in international trade data

How to Access a Sulfaquinoxaline Sodium Global Buyers List

While comprehensive public buyer lists are typically proprietary information held by market research firms and trade data providers, several legitimate avenues exist for identifying and connecting with global buyers:

1. Market Research Reports

Specialized reports such as the Sulfaquinoxaline sodium (SQ-Na) (CAS 967-80-6) Market Research Report 2025 provide detailed information on:

  • Regional and global producers
  • Suppliers (importers and local distributors)
  • Consumers in various markets
  • Contact details for key market participants

The Global Market Report of Sulfaquinoxaline sodium (CAS 967-80-6) similarly offers comprehensive data on manufacturers, consumers, and traders worldwide.

2. Pharmaceutical Databases and Platforms

PharmaCompass: Offers a searchable list of Sulfaquinoxaline Sodium API manufacturers, exporters, and distributors, sortable by GMP, USDMF, JDMF, KDMF, CEP (COS), and other criteria. Users can send inquiries and establish direct connections with preferred manufacturers or suppliers.

Biocompare: Lists chemicals and reagents suppliers, providing another avenue for identifying potential buyers and sellers.

3. Trade Data Platforms

Eximpedia: Provides import and export trade data for veterinary products under HS code 29359000, including specific shipments of Sulfaquinoxaline Sodium. This platform can reveal:

  • Actual import shipments
  • Buyer and seller information
  • Quantity and value data
  • Origin and destination countries

Volza: Offers bills of lading and shipment data for pharmaceutical raw materials, including Sulfaquinoxaline Sodium.

4. Industry Trade Shows and Conferences

Veterinary pharmaceutical trade shows and API conferences provide networking opportunities to connect with buyers directly. Events such as:

  • CPhI Worldwide
  • VIV Asia
  • IPPE (International Production & Processing Expo)
  • EuroTier

These events attract global buyers and sellers in the animal health sector.

5. B2B Platforms

Online B2B marketplaces like Made-in-China.com list suppliers and facilitate buyer-seller connections. While these platforms primarily feature suppliers, they also attract buyers seeking sourcing opportunities.

6. Trade Associations

Industry associations such as:

  • International Federation for Animal Health (IFAH)
  • European Federation of Animal Health (FEDIAF)
  • National associations in key markets

These organizations maintain member directories that can help identify potential buyers.

Regional Buyer Profiles

Asia-Pacific Buyers

The Asia-Pacific region is both the largest producer and a major consumer of Sulfaquinoxaline Sodium.

China: Beyond being the world’s largest manufacturer, China has a substantial domestic market driven by its massive poultry and livestock sectors. Chinese buyers include veterinary pharmaceutical companies, feed additive manufacturers, and trading companies.

India: A growing market with an expanding poultry industry. Indian buyers include pharmaceutical companies like Siflon Pharma Private Limited and trading companies.

Vietnam: Documented as an importer of Sulfaquinoxaline Sodium from Chinese manufacturers.

Southeast Asia: Malaysia, Indonesia, Thailand, and the Philippines represent growing markets for veterinary pharmaceuticals.

European Buyers

European buyers are characterized by stringent quality requirements and regulatory compliance standards.

Key Markets: Germany, United Kingdom, France, Italy, Spain, Netherlands

Regulatory Environment: Buyers typically require:

  • GMP certification
  • CEP/COS (Certificate of Suitability)
  • DMF (Drug Master File) documentation

Notable Entities: Ceva (Italy) is documented as a veterinary pharmaceutical company in the region.

North American Buyers

United States: The largest market in North America, with buyers requiring FDA compliance and DMF submissions.

Canada: Home to distributors like Toronto Research Chemicals and Adooq Bioscience.

Mexico: An important market with growing livestock production.

Trade Data and Import/Export Insights

Analysis of trade data reveals important patterns in the Sulfaquinoxaline Sodium global trade:

HS Code Classification

Sulfaquinoxaline Sodium is typically classified under HS code 29359000, covering “sulfonamides”. This code encompasses various veterinary pharmaceutical raw materials.

Documented Shipments

Recent trade data shows shipments from Chinese manufacturers to importing countries:

  • Exporter: Wugan Pharmaceutical (Suzhou) Co., Ltd.
  • Destination: Vietnam
  • Product: Sulfaquinoxaline Sodium
  • Quantity: 200 units (typical packaging in 25kg drums)

Additional trade records indicate shipments from Nanhai Beisha Pharmaceutical to various international destinations.

Packaging and Specifications

Standard packaging for international trade typically involves 25kg drums. Buyers often require:

  • Batch number documentation
  • Manufacturing and expiry dates
  • Certificate of Analysis (COA)
  • Compliance with importing country regulations

Strategic Considerations for Buyers and Sellers

For Buyers (Importers and Distributors)

Quality Assurance: Prioritize suppliers with established regulatory certifications including GMP, US FDA compliance, EDQM accreditation, and CEP/COS.

Supply Chain Reliability: Evaluate supplier production capacity and track record. Major manufacturers like Nanhai Beisha maintain annual outputs exceeding 3,000 metric tons.

Regulatory Compliance: Ensure imported products meet local regulatory requirements for veterinary pharmaceuticals in your target market.

Price Considerations: Sulfaquinoxaline Sodium prices vary by region and are influenced by market conditions, regulatory changes, and negotiated pricing deals.

For Sellers (Manufacturers and Exporters)

Market Intelligence: Utilize market research reports to identify high-potential markets and understand regional pricing dynamics.

Regulatory Preparation: Prepare DMFs, CEP applications, and other regulatory documentation required by target markets.

Distribution Partnerships: Establish relationships with local distributors and importers in target regions.

Digital Presence: Maintain visibility on pharmaceutical databases, B2B platforms, and industry directories.

Market Trends and Future Outlook

Growth Drivers

Increasing Meat Consumption: Rising global demand for poultry and livestock products drives the need for effective veterinary treatments.

Intensive Farming Expansion: The growth of large-scale, intensive livestock operations increases demand for preventive veterinary medicines.

Regulatory Evolution: Stricter food safety regulations and quality standards create opportunities for suppliers with strong compliance records.

Technological Advancements: Innovation in formulation and delivery methods may expand application areas.

Challenges

Regulatory Complexity: Navigating varying regulatory requirements across different markets remains challenging.

Price Volatility: Raw material costs and market conditions can affect pricing stability.

Competition: The market features established players with significant production capacity, creating competitive pressure.

CÔNG TY TNHH HÓA CHẤT NAVY
NEGOCIAR S A C
LABORATORIO QUIMICO VETERINARIO LABET S A C LABET S A C
PT JANNISIKA SUMBER JAYA
PROMUNE S A C
SQUARE PHARMACEUTICALS PLC CHANGED
UNICHEMIE INTERNATIONAL PRIVATE LIMITED
DRESDEN S A
LABORATORIOS DROGAVET S A C
LEADS PHARMA PVT LTD
PT CIPTA PRIMA CHEMINDO
CÔNG TY TNHH XUẤT NHẬP KHẨU NEW LIFE
LABORATORIOS BIOMONT S A
MEDION FARMA JAYA
CHROMATOPAK ANALYTICAL INSTRUMENTATION INDIA PVT
CÔNG TY CỔ PHẦN THÀNH NHƠN
CÔNG TY TNHH RUBY
CÔNG TY TNHH THUỐC THÚ Y NĂM THÁI
M S LEADS PHARMA PRIVATE LIMITED
MEDISEL KENYA LIMITED
PRODUCTOS QUIMICOS VETERINARIOS S A C PROQUIMVET S A C
DAIDO IMPEX CORP
COSMOS LTD
CÔNG TY TNHH THƯƠNG MẠI H B C
CÔNG TY TNHH VẬT TƯ KHOA HỌC CÔNG NGHỆ T T
DAIDO IMPEX
DAIDO IMPEX CORPORATION
FARM AID GROUP
HILTON PHARMA PRIVATE LIMITED
JANNISIKA SUMBER JAYA
MARIDAV GHANA LIMITED
MERCANTIL S A
NOBLE PHARMA
PT DILIMAS MANDIRI
QUIMICA S K R EIRL
ADIV CUSTOMS AGENT AND INTL TRANSPOR
ADVANCED CHEMICAL INDUSTRIES LTD
ALBION LABORATORIES LIMITED
BENGAL REMEDIES LIMITED
BM SCIENTIFIC PRIVATE LIMITED
CÔNG TY CỔ PHẦN DƯỢC PHẨM CÔNG NGHỆ CAO KEYBIO VIỆT NAM
CÔNG TY TNHH AMOLI VIỆT NAM
CÔNG TY TNHH EMIVEST FEEDMILL VIỆT NAM CHI NHÁNH SẢN XUẤT THUỐC THÚ Y
ELKO ORGANIZATION PVT LIMITED
EMMANUEL HECTOR ONYEJI
FAMOUS PACIFIC SHIPPING LANKA PVT LIMITED
FARMACO SA
FARMCHEMIE PVT LIMITED
FARMCHEMIE PVT LTD
GLOBAL LAB SOLUTIONS
GROT DEL PERU SOCIEDAD ANONIMA CERRADA GROT PERU S A C
HEMSONS INTERNATIONAL PVT LTD
HILTON PHARMA PVT LTD
INDUSTRIAS FARMACEUTICAS VETERINARIAS G T S A C
INTL FARMACEUTICA VETERINARIA FARMATEC LTDA
M S HILTON PHARMA PVT LIMITED
MSL DEL PERU S A C
NAUTIC LOGISTICS
PEERTOP PHARMACEUTICALS LTD
PRIX PHARMACEUTICA PRIVATE LIMITED
PRIX PHARMACEUTICA PVT LTD
PT BINA SAN PRIMA
REFERANS KIMYA LABORATUVAR CIHAZLARI ELEKTRONIK VE BILGISAYAR HIZMETLERI SANAYI VE TICARET LIMITED SIRKETI
RENATA PLC CHANGED FROM RENATA
RRP PHARMACEUTICAL ANIMAL HEALTH
SBS PHILIPPINES CORP
SBS PHILIPPINES CORPORATION
SOUTHCARGO PERU S A
THE ACME LABORATORIES LIMITED
VELKON CARGO PERU SAC
VETZ PHARMACEUTICAL PVT LTD
VITRACE NUTRITION LTD

Conclusion

The Sulfaquinoxaline Sodium global market offers significant opportunities for both buyers and sellers in the veterinary pharmaceutical sector. With steady market growth projected through 2033 and expanding demand across multiple regions, understanding the global buyer landscape is essential for success.

While a comprehensive public buyers list may not be readily available, the strategies outlined in this guide—including market research reports, pharmaceutical databases, trade data platforms, and industry networking—provide effective pathways to identify and connect with qualified global buyers.

For manufacturers and exporters, maintaining high-quality standards, regulatory compliance, and a strong market presence are key to attracting buyers. For importers and distributors, thorough due diligence on suppliers and understanding regional market dynamics will ensure successful sourcing partnerships.

As the global animal health market continues to evolve, Sulfaquinoxaline Sodium remains a vital component of veterinary medicine, and those who navigate its global supply chain effectively will be well-positioned for success.


Disclaimer: This article provides general market information and should not be construed as a complete buyers list or business advice. Buyers and sellers should conduct their own due diligence and verify all information through appropriate channels.

error: Content is protected !!